Mettler Toledo International Inc header image

Mettler Toledo International Inc

MTD

Equity

ISIN US5926881054 / Valor 831090

New York Stock Exchange, Inc (2024-10-24)
USD 1,293.38-2.04%

Mettler Toledo International Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Mettler Toledo International Inc. is a global provider of precision instruments and services for various applications across research and development, quality control, production, logistics, and retail sectors. The company specializes in offering a wide range of high-performance weighing solutions, analytical instruments, and automated chemistry solutions for laboratories engaged in research and development. For quality control processes, Mettler Toledo supplies analytical balances, titrators, electrodes, densimeters, refractometers, melting point measurement instruments, and pipettes, all designed to ensure rapid and precise measurements. In the production sphere, the company's measurement probes and connectivity solutions support industries, including pharmaceuticals and biotechnology, in maintaining product quality and regulatory compliance. Mettler Toledo also provides industrial weighing scales, product inspection systems, and logistics solutions to enhance productivity, ensure product quality and safety, and optimize supply chain efficiency. Through its comprehensive product offerings, Mettler Toledo caters to a diverse clientele worldwide, aiming to improve operational efficiencies and support the scientific research community.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (20.08.2024):

Sales Decline

Mettler Toledo International Inc. reported a 4% decline in total sales for the second quarter of 2024 compared to the same period in the previous year. In local currency, sales decreased by 2%, with currency fluctuations contributing to a 2% reduction in sales growth.

EPS Performance

The company's net earnings per diluted share (EPS) for Q2 2024 were $10.37, up from $9.69 in the prior-year period. This figure includes a one-time non-cash tax benefit of $1.07 per share. Adjusted EPS, however, decreased by 5% to $9.65 from $10.19 in the previous year.

Regional Sales

By region, Mettler Toledo International Inc. saw a 5% increase in reported sales in Europe and a 2% increase in the Americas. However, sales in Asia and the Rest of the World declined by 16% during the second quarter of 2024.

Operating Profit

Adjusted Operating Profit for Mettler Toledo International Inc. in Q2 2024 amounted to $284.1 million, down from $307.7 million in the prior-year period. This represents an 8% decrease in adjusted operating profit compared to the same quarter last year.

Future Outlook

Management anticipates that local currency sales for the third quarter of 2024 will increase by approximately 1%, with Adjusted EPS forecasted to be between $9.90 and $10.05. For the full year, local currency sales are expected to grow by around 2%, with Adjusted EPS projected to be in the range of $40.20 to $40.50, representing a growth of 6% to 8%.

Summarized from source with an LLMView Source

Key figures

30.4%1Y
-12.0%3Y
88.3%5Y

Performance

31.7%1Y
31.9%3Y
32.4%5Y

Volatility

Market cap

27432 M

Market cap (USD)

Daily traded volume (Shares)

40,269

Daily traded volume (Shares)

1 day high/low

1320.15 / 1290.18

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Intellia Therapeutics Inc
Intellia Therapeutics Inc Intellia Therapeutics Inc Valor: 32256913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%USD 15.95
Array Technologies Inc
Array Technologies Inc Array Technologies Inc Valor: 57373259
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.38%USD 6.44
MaxLinear Inc
MaxLinear Inc MaxLinear Inc Valor: 11132674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%USD 14.85
Beam Therapeutics Inc
Beam Therapeutics Inc Beam Therapeutics Inc Valor: 50337226
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.44%USD 21.55
Prothena Corporation PLC
Prothena Corporation PLC Prothena Corporation PLC Valor: 20224443
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.96%USD 15.30
Immunocore Holdings PLC
Immunocore Holdings PLC Immunocore Holdings PLC Valor: 59524572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.92%USD 32.80
JOYY Inc
JOYY Inc JOYY Inc Valor: 51728275
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%USD 34.12
Relay Therapeutics Inc
Relay Therapeutics Inc Relay Therapeutics Inc Valor: 55675918
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.75%USD 6.02
Tandem Diabetes Care Inc
Tandem Diabetes Care Inc Tandem Diabetes Care Inc Valor: 38586336
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.29%USD 31.35
Sonos Inc
Sonos Inc Sonos Inc Valor: 37722921
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%USD 12.78